Title |
Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial |
|---|---|
Involved |
Anne Sophie Kubasch (Verfasser)
P. Peterlin (Verfasser) T. Cluzeau (Verfasser) K. S. Götze (Verfasser)
K. Sockel (Verfasser)
R. Teipel (Verfasser) M. Jentzsch (Verfasser) H. Attalah (Verfasser) M. Sebert (Verfasser) F. Chermat (Verfasser) S. Gloaguen (Verfasser) M. Puttrich (Verfasser) M. Cross (Verfasser) M. Schneider (Verfasser) S. Kayser (Verfasser) D. Schipp (Verfasser) A. Giagounidis (Verfasser) I. Tirado-Gonzalez (Verfasser) A. Descot (Verfasser) A. van de Loosdrecht (Verfasser) A. Weigert (Verfasser) Klaus Hans Metzeler (Verfasser) P. Fenaux (Verfasser) H. Medyouf (Verfasser) Uwe Platzbecker (Verfasser) L. Ades (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Leukemia : normal and malignant hemopoiesis ; a peer-reviewed journal 37, 11, 21.9.2023, date:11.2023, Seite 2309-2313 |
Published |
2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Public Health.
Internal Medicine. Intensive Care Medicine. Cancer Biology.
Oncology.
Hematology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024012211520987546660 (URN) |
Record ID |
1316795144 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: